113: How Do I Choose a Major as a Nontraditional Premed Student?
Preeclampsia screening method found superior to current tests
New research highlights a more accurate way to screen for preeclampsia in pregnant women than currently recommended methods.
New research highlights a more accurate way to screen for preeclampsia in pregnant women than currently recommended methods. Published early online in
, the study challenges the UK's current guidelines on the management of hypertensive disorders during pregnancy.
Preeclampsia (PE) affects approximately 2% to 3% of pregnancies and can have serious health effects for both the mother and child. The condition is characterized by high blood pressure. Some affected women develop very severe disease associated with kidney, liver, bleeding and neurological problems. The fetus may experience impaired growth and possibly die. Risks are especially high when PE leads to preterm birth before 37 weeks' gestation (preterm-PE), which itself is associated with long-term health issues for the children.
Recent evidence suggests that giving low-dose aspirin to women at high risk of the disorder can reduce the prevalence of the severest form of preeclampsia by more than 60%, but the treatment must be started before 16 weeks' gestation. Therefore, early detection is key. In the UK, identification of high-risk women who could benefit from aspirin is based on a checklist of maternal characteristics and medical history as defined by the National Institute for Health and Care Excellence (NICE) guidelines. An alternative approach combines known risk factors with the results of various maternal biophysical and biochemical measurements taken at 11 to 13 weeks' gestation: mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI), and serum placental growth factor (PlGF); known as the first-trimester combined test.
study -- called the Screening ProgRamme for prE-Eclampsia (SPREE) study -- was designed to compare the performance of first-trimester screening for PE by this alternative approach with that of the current NICE method. The study was conducted in seven National Health Service (NHS) maternity hospitals in England between April and December 2016. Singleton pregnancies at 11 to 13 weeks' gestation had recordings of maternal characteristics and medical history, as well as measurements of MAP, UtA-PI, and PlGF.
PE occurring at any point during pregnancy (all-PE) was found in 473 (2.8%) of the 16,747 pregnancies in the study, and preterm-PE was seen in 142 (0.8%). The detection rates of the NICE checklist for all-PE and preterm PE were 30.4% and 40.8%, respectively. Furthermore, compliance with the NICE recommendation that women at high risk for PE should be treated with aspirin from the first trimester was only 23%. If screening was carried out by the first-trimester combined test, the detection rates for all-PE and preterm PE were increased to 42.5% and 82.4%, respectively.
The findings indicate that the use of the simple algorithm based on maternal characteristics and easily measurable markers can identify approximately 80% of women who would go on to develop preterm-PE and would therefore benefit from taking prophylactic aspirin. The first-trimester combined test is freely available as a simple and user-friendly risk calculator via
"The SPREE study has provided definitive proof to support risk-based screening for preterm-PE using various biomarkers. It is now time to revise the professional guidelines and to move away from using a checklist-based method for screening." said co-senior author Liona Poon, MD, of King's College London, in London.
Basky Thilaganathan, MD, PhD, the journal's Editor-in-Chief, noted that the findings have important clinical implications. "Poon and colleagues have demonstrated that effective early pregnancy screening for preeclampsia is possible in a routine NHS hospital setting. They make a compelling case for the routine implementation of this protocol to halve the cases of early-onset severe preeclampsia cases in the UK" he said.
Min Yi Tan, David Wright, Argyro Syngelaki, Ranjit Akolekar, Simona Cicero, Deepa Janga, Mandeep Singh, Elena Greco, Alan Wright, Kate Maclagan, Liona C Poon, and Kypros H Nicolaides.
Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE
Wiley. "Preeclampsia screening method found superior to current tests." ScienceDaily. ScienceDaily, 14 March 2018.
Wiley. (2018, March 14). Preeclampsia screening method found superior to current tests.
. Retrieved August 28, . Retrieved August 28 Uta Pre Medical
Wiley. "Preeclampsia screening method found superior to current tests." ScienceDaily. www.sciencedaily.com/releases/2018/03/180314092328.htm (accessed August 28, 2018).
A new test may help to rapidly diagnose preeclampsia in pregnant women. Elevated levels of fetal hemoglobin in the blood may play a role in the development of kidney damage associated with ...
New Treatment May Help Overcome Common Pregnancy-Related Complication
In pregnant women with preeclampsia, a procedure used to remove a protein called sFlt-1 from the blood reduced the amount of protein excreted in the urine and stabilized blood pressure. Pregnancy ...
Preeclampsia May Share Cause With Disorders Such as Alzheimer's
A potential cause of -- and a better diagnostic method for -- preeclampsia has been discovered by researchers. Preeclampsia is one of the most deadly and poorly understood pregnancy-related ...
Closer to Detecting Preeclampsia: Biomarkers Found in Urine, Blood
Researchers have found a set of biomarkers in urine and serum samples that were different between women with preeclampsia, women with normal pregnancies and women who were not pregnant. These ...
Below are relevant articles that may interest you. ScienceDaily shares links and proceeds with scholarly publications in the
Consuming Milk at Breakfast Lowers Blood Glucose Throughout the Day
Largest Brain Study of 62,454 Scans Identifies Drivers of Brain Aging
How Sleep Loss May Contribute to Adverse Weight Gain
Severe Bloating Uta Pre Medical , Severe Bloating
How We Judge Personality from Faces Depends on Our Beliefs About How Personality Works
Moderate Carbohydrate Intake May Be Best for Health, Study Suggests
The Spotlight of Attention Is More Like a Strobe Light
Secret Tunnels Discovered Between the Skull and the Brain
Deep Forehead Wrinkles May Signal a Higher Risk for Cardiovascular Mortality
Movement Control: How Our Brain Responds to Unexpected Situations
Watching the Clock: Faster Countdowns May Make People More Patient
When Confronted, Uta Pre Medical
Meet the Virtual Pooch That Could Help Prevent Dog Bites
The Spotlight of Attention Is More Like a Strobe Light
A Video Game Can Change the Brain, May Improve Empathy in Middle Schoolers
Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:
Keep up to date with the latest news from ScienceDaily via social networks:
Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
or by other parties, where indicated. All rights controlled by their respective owners.
Content on this website is for information only. It is not intended to provide medical or other professional advice.
Views expressed here do not necessarily reflect those of ScienceDaily, its staff, its contributors, or its partners.
Financial support for ScienceDaily comes from advertisements and referral programs, where indicated.
0 Reviews:
Post Your Review